NuVasive gets FDA OK for expanded use of Monolith Corpectomy System

NuVasive gets FDA clearance for expanded use of Monolith Corpectomy System  announced it has received 510(k) clearance from the U.S. FDA for expanded use of its Monolith Corpectomy System, providing surgeons with a modular PEEK interbody solution for cervical corpectomy procedures. The FDA 510(k) indications for expanded use of the company’s Monolith Corpectomy System include procedures in the cervical spine to treat a diseased or damaged vertebral body caused by fracture, tumors, osteomyelitis or to support reconstruction following corpectomy performed to achieve decompression of the spinal cord and neural tissue in cervical degenerative disorders.
https://thefly.com/landingPageNews.php?id=2834517